Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Return on Capital Employed (2021 - 2025)

Cytek Biosciences (CTKB) has disclosed Return on Capital Employed for 3 consecutive years, with 0.06% as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Return on Capital Employed fell 6.0% year-over-year to 0.06%, compared with a TTM value of 0.06% through Dec 2023, down 6.0%, and an annual FY2024 reading of 0.05%, up 1.0% over the prior year.
  • Return on Capital Employed was 0.06% for Q4 2023 at Cytek Biosciences, down from 0.04% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.05% in Q3 2021 and bottomed at 0.06% in Q4 2023.
  • Average Return on Capital Employed over 3 years is 0.01%, with a median of 0.0% recorded in 2022.
  • The sharpest move saw Return on Capital Employed dropped -3bps in 2022, then fell -6bps in 2023.
  • Year by year, Return on Capital Employed stood at 0.02% in 2021, then plummeted by -118bps to 0.0% in 2022, then tumbled by -1477bps to 0.06% in 2023.
  • Business Quant data shows Return on Capital Employed for CTKB at 0.06% in Q4 2023, 0.04% in Q2 2023, and 0.02% in Q1 2023.